deferoxamine

Generic: deferoxamine mesylate

Labeler: fresenius kabi usa, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name deferoxamine
Generic Name deferoxamine mesylate
Labeler fresenius kabi usa, llc
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Active Ingredients

deferoxamine mesylate 95 mg/mL

Manufacturer
Fresenius Kabi USA, LLC

Identifiers & Regulatory

Product NDC 63323-599
Product ID 63323-599_6e384a23-a8c4-455a-b84b-847393d491e6
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078718
Listing Expiration 2026-12-31
Marketing Start 2009-12-15

Pharmacologic Class

Classes
iron chelating activity [moa] iron chelator [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63323599
Hyphenated Format 63323-599

Supplemental Identifiers

RxCUI
1731345 1731350
UPC
0363323599300 0363323597108
UNII
V9TKO7EO6K

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name deferoxamine (source: ndc)
Generic Name deferoxamine mesylate (source: ndc)
Application Number ANDA078718 (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 95 mg/mL
source: ndc
Packaging
  • 1 VIAL in 1 BOX (63323-599-30) / 21.1 mL in 1 VIAL
source: ndc

Packages (1)

63323-599-30 1 VIAL in 1 BOX (63323-599-30) / 21.1 mL in 1 VIAL

Ingredients (1)

deferoxamine mesylate (95 mg/mL)

Linked Drug Pages (1)

Deferoxamine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "6e384a23-a8c4-455a-b84b-847393d491e6", "openfda": {"upc": ["0363323599300", "0363323597108"], "unii": ["V9TKO7EO6K"], "rxcui": ["1731345", "1731350"], "spl_set_id": ["d91e16df-8daa-4cd2-86a2-273eaa2446e0"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 BOX (63323-599-30)  / 21.1 mL in 1 VIAL", "package_ndc": "63323-599-30", "marketing_start_date": "20091215"}], "brand_name": "Deferoxamine", "product_id": "63323-599_6e384a23-a8c4-455a-b84b-847393d491e6", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Iron Chelating Activity [MoA]", "Iron Chelator [EPC]"], "product_ndc": "63323-599", "generic_name": "DEFEROXAMINE MESYLATE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Deferoxamine", "active_ingredients": [{"name": "DEFEROXAMINE MESYLATE", "strength": "95 mg/mL"}], "application_number": "ANDA078718", "marketing_category": "ANDA", "marketing_start_date": "20091215", "listing_expiration_date": "20261231"}